Phoenix—Mounting evidence suggests that liposomal bupivacaine is the preferred analgesia for patients undergoing total hip replacement surgery.
The latest data come from a retrospective study, presented at the annual meeting of the American College of Clinical Pharmacy (poster 24), showing intraoperative, local site injections of liposomal bupivacaine (Exparel, Pacira) in patients undergoing a total hip arthroplasty (THA) decreased the hospital length of stay (LOS) by a half-day, improved